跳至主要内容
临床试验/NCT00869011
NCT00869011Unknown3 期

Effects of Physical Activity on the Endothelial and Cardiac Function of Patients With Renal Cell Carcinoma Receiving a Thyrosine Kinase Inhibitor (Sunitinib)

Charite University, Berlin, Germany2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2009年12月最近更新:
适应症

试验速览

阶段
3 期
入组人数
70
试验地点
2
主要终点
Fatigue

研究概览

简要总结

In this randomized, controlled trial the investigators evaluate the effects of an exercise program lasting for 12 weeks on the physical performance, the cardiovascular function (24h blood pressure, rest blood pressure and hear function) and the fatigue and mood of patients with renal cell carcinoma undergoing a therapy with Sunitinib.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 to 75 years
  • Understanding of written German
  • Treatment with Sunitinib
  • Ability to walk

排除标准

  • Cardiovascular, pulmonary or osteoarticular disease which can be aggravated by exercise
  • BMI < 18 or > 30

结局指标

主要结局

Fatigue

时间窗: 12 weeks

次要结局

  • VO2max(12 weeks)
  • Depression score(12 weeks)
  • Systolic and diastolic blood pressure (24 h)(12 weeks)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Exercise for Patients With Renal Cell Cancer... | 临床试验